[ad_1]
Biontech announced on Monday that their vaccine was 90% effective. According to media reports, Switzerland is now also negotiating with the German pharmaceutical company.
-
Switzerland is negotiating the Corona vaccine with Biontech.
-
Alain Berset will require an additional 100 million francs for the purchase.
-
It is not yet clear what the vaccination strategy will be.
German pharmaceutical company Biontech has concluded supply agreements for its corona vaccine with several countries and the EU. As the “Blick” writes, Switzerland is also facing a purchase agreement with the Mainz-based company.
According to the newspaper, the negotiations are at the finish line. Even before the vaccine was announced, Switzerland was already facing a preliminary contract. It is still unclear whether Switzerland will join the EU or agree on its own agreement.
BAG’s Stefan Kuster didn’t want to lean too far out the window during Tuesday’s press conference. Asked if Switzerland is negotiating with Biontech, he said: “The federal government is still in contact with various manufacturers. I won’t tell you any further details. “
“Take vaccinations in the first half of the year”
According to sources in the newspaper, Health Minister Alain Berset will ask for another 100 million francs for the purchase of vaccines during the Federal Council meeting on Wednesday. It is still unclear whether this money is linked to the purchase of the corona vaccine from Biontech. So far, the Federal Council has set aside 300 million francs for vaccines and has already signed several contracts. In mid-August, the federal government secured 4.5 million doses of the vaccine from Moderna. Another contract came in mid-October, with the pharmaceutical company Astrazeneca.
Samia Hurst (48), Vice President of the Corona Scientific Task Force, assumes that several vaccines will be available by mid-2021. A spokesperson for the BAG at Blick’s request: “We assume that the first vaccinations will be carried out in the first half of 2021” . However, Hurst warned the Swiss population. The corona vaccine from pharmaceutical companies Biontech and Pfizer is raising great hopes in dark times. However, Switzerland shouldn’t be negligent in the fight against the Covid 19 pandemic, Hurst said.
Experts are currently working on a possible vaccination strategy. According to Kuster, this depends on the vaccine in question. It just seems clear that risk groups and their environment will come first.
Mainz-based Biontech and pharmaceutical company Pfizer announced on Monday that their vaccine offers up to 90% protection against Covid-19 disease. They want to deliver 50 million doses of the vaccine this year and about 1.3 billion in 2021 – worldwide. Each person must be vaccinated twice. (SDA)
[ad_2]
Source link